Cullinan Therapeutics, Inc. (CGEM)
NASDAQ · Healthcare
Cullinan Therapeutics, Inc. Income Statement 2020–2022
| Dec 2022 | Dec 2021 | Dec 2020 | |
|---|---|---|---|
| Revenues | |||
| Revenue | 0 | 18.9M | 0 |
| Gross Profit | — | — | — |
| Profitability | |||
| Operating Income | 144.6M | -68.0M | -60.3M |
| EBITDA | 144.7M | -67.9M | -60.3M |
| Net Income | 111.2M | -65.6M | -51.8M |
| Per Share Data | |||
| EPS (diluted) | — | — | — |
| Shares Outstanding (dil.) | 47M | 43M | 30M |
Cullinan Therapeutics, Inc. Income Statement — FAQ
Cullinan Therapeutics, Inc. (CGEM) income statement over the last 3 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see CGEM's income statement history?
The chart and table above show Cullinan Therapeutics, Inc.'s income statement by year and by quarter, including the growth rate.